Healthtech funding in 2013
European Healthtech startup funding raised during 2013.
In 2013, 108 European Healthtech companies closed 121 funding rounds and raised €631M in equity funding (excluding debt and grants). Debt rounds added €914k. Switzerland led by capital raised, and Sofinnova Partners was the most active investor. Data as of 6 Nov 2026.
Equity funding
€631M
excl. debt & grants · +€914k debt
Funding rounds
121
Companies
108
Top country
Switzerland
Healthtech: last three years
change vs the year before| Year | Equity | Change | Rounds | Change | Debt |
|---|---|---|---|---|---|
| 2011 | €528M | +52.8% | 66 | +46.7% | — |
| 2012 | €480M | -9.1% | 74 | +12.1% | — |
| 2013 | €631M | +31.5% | 121 | +63.5% | €914k |
Rank among sectors
#2
13.2% of sector funding
Debt financing
€914k
0.1% of total
Top-10 round share
53.8%
of disclosed capital
Rounds ≥ €100M
1
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, 2013 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jan | €15M | 10 |
| Feb | €6.8M | 7 |
| Mar | €41M | 10 |
| Apr | €153M | 12 |
| May | €79M | 9 |
| Jun | €124M | 11 |
| Jul | €31M | 9 |
| Aug | €32M | 9 |
| Sep | €78M | 14 |
| Oct | €100M | 13 |
| Nov | €77M | 13 |
| Dec | €10M | 4 |
Top countries
by € raisedHealthtech — top countries by capital, 2013 — interactive chart.
Data table
| Healthtech — top countries by capital, 2013 | |
|---|---|
| Switzerland | €152M |
| France | €151M |
| Finland | €111M |
| UK | €76M |
| Denmark | €68M |
| Germany | €43M |
| Ireland | €43M |
| Netherlands | €35M |
Stage mix
by € raisedHealthtech — stage mix, 2013 — interactive chart.
Data table
| Healthtech — stage mix, 2013 | |
|---|---|
| Series B | €163M |
| Growth/Late | €133M |
| Grant | €116M |
| Series C | €97M |
| Other | €78M |
| Series A | €74M |
| Series D+ | €48M |
| Early VC | €22M |
| Seed | €15M |
| Debt | €914k |
Largest equity rounds
by disclosed amount, 2013| Company | Stage | Date | Amount |
|---|---|---|---|
| Symphogen | Growth/Late | May 2013 | €41M |
| Auris Medical | Series C | Apr 2013 | €40M |
| Opsona | Series C | Apr 2013 | €33M |
| GenSight Biologics | Series A | Apr 2013 | €32M |
| Merus | Series B | Oct 2013 | €31M |
| Evotec | Growth/Late | Sep 2013 | €30M |
| Biocartis | Series D+ | Nov 2013 | €30M |
| ADC Therapeutics | Growth/Late | Oct 2013 | €30M |
| ObsEva | Series A | Aug 2013 | €26M |
| MISSION Therapeutics | Series B | Nov 2013 | €24M |
Largest debt rounds
debt financing, 2013; not in the equity total| Company | Stage | Date | Amount |
|---|---|---|---|
| Cella Energy | Debt | Mar 2013 | €914k |
Top investors
most active in 2013, by deal count- Sofinnova Partners5 deals
- Bpifrance4 deals
- Wayra4 deals
- IDInvest Partners3 deals
- SEED Capital3 deals
- Amgen Ventures2 deals
- Capricorn Partners2 deals
- Index Ventures2 deals
- Lanzadera2 deals
- Novartis Venture Fund2 deals
Source: Tech.eu Funding Explorer · data as of 6 Nov 2026 · licence CC BY 4.0 · Methodology